Under RAPS

Posted 01 June 2010 | By

Due diligence is the term used to describe the process of evaluating potential business transactions or partnerships to identify and mitigate risk. As healthcare products, including pharmaceuticals and biotechnology-based products, are developed, manufactured and marketed in an increasingly complex and global regulatory environment, various agencies' regulations and intricate regulatory considerations can make or break potential business deals, large and small.

Categories:

Regulatory Focus newsletters

All the biggest regulatory news and happenings.

Subscribe